MAUREEN OCONNELL

CIK 1111318 · EVP, CAO & CFO · last filed 2026-03-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.53M

Companies

6

Total Filings

93

Lifetime Open-Market Net

-$19.77M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TEX Director 16,351 $63.80 $1.04M $0 2 2026-03-09
REV Group, Inc. (REVG) Delisted Director 2,105 $63.90 $134.5K $0 5 2026-02-02
ACTG Director 272,603 $4.68 $1.28M $94.5K 9 2025-06-03
HHS Director 25,414 $2.53 $64.2K $0 3 2020-09-02
Sucampo Pharmaceuticals, Inc. (SCMP) Delisted Director 0 $0 6 2018-02-13
SCHL EVP, CAO & CFO 71,771 $43.89 $3.15M -$19.86M 68 2017-09-26

Recent Filings · Page 8 of 10

93 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2011-10-11 SCHL Grant (A) +13,840 $390.0K EDGAR
2011-09-29 SCHL Mixed +1,639 $46.4K EDGAR
2011-09-21 SCHL Mixed +837 $22.9K EDGAR
2011-09-06 SCHL Mixed +3,676 $95.2K EDGAR
2011-07-25 SCHL Tax (F) −2,166 -$61.1K EDGAR
2010-09-24 SCHL Grant (A) +12,000 $0 EDGAR
2010-09-21 SCHL Tax (F) −522 -$13.7K EDGAR
2010-09-02 SCHL Mixed +1,874 $45.2K EDGAR
2010-08-25 SCHL Tax (F) −1,858 -$42.7K EDGAR
2010-07-27 SCHL Tax (F) −348 -$9.0K EDGAR
Showing 7180 of 93
Page 8 of 10
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.